Edited by Paolo Martelletti, Dimos-Dimitrios Mitsikostas and Francesco Pierelli
Citation: The Journal of Headache and Pain 2017 18(Suppl 1):111
Volume 18 Supplement 1
Publication costs for this supplement were funded by the 11th European Headache Federation Congress and the 31st National Congress of the Italian Society for the Study of Headaches. PM is on the advisory boards for Allergan, Amgen, Teva, Novartis, ElectroCore, and speaker bureau for Allergan, Bayer, Sanofi. PM has received reimbursement from European Medicines Agency, Springer Nature and funding from Elytra Pharma. PM is an employee of Springer Nature. DDM has received honoraria from lecturing, research or clinical trial grants and consulting fees from Allergan, Amgen, Biogen, Brain Therapeutics, Eli Lily, Gammacore, Genesis Pharma, Novartis, Sanofi-Genzyme and Teva. FP declares no competing interest.
Rome, Italy01-03 December 2017
Edited by Paolo Martelletti, Dimos-Dimitrios Mitsikostas and Francesco Pierelli
Citation: The Journal of Headache and Pain 2017 18(Suppl 1):111
The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Speed
39 days to first decision for reviewed manuscripts only
21 days to first decision for all manuscripts
79 days from submission to acceptance
22 days from acceptance to publication
Citation Impact
4.797 - 2-year Impact Factor
4.536 - 5-year Impact Factor
1.164 - Source Normalized Impact per Paper (SNIP)
1.339 - SCImago Journal Rank (SJR)
Usage
907,595 Downloads
1921 Altmetric mentions